Migraine prophylaxis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • AbbVie Deutschland GmbH & Co. KG Commercial
    ATOGEPANT
    2022-501172-25-00 9 countries 2024 n=475
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AbbVie Deutschland GmbH & Co. KG Commercial 1 Phase III 0
New trials by year
2024
1
← All indication landscapes